Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset.

about

Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S).

P2860

Q42371744-53BC9D89-9610-4D60-88F4-C37F1EC3D9FE

P2860

Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset.

Item

http://www.wikidata.org/entity/Q35837580

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Type 1 Diabetes Prevention in ...... CD8⁺T Effector Memory Subset.

@ast

Type 1 Diabetes Prevention in ...... CD8⁺T Effector Memory Subset.

@en

type

Item

label

Type 1 Diabetes Prevention in ...... CD8⁺T Effector Memory Subset.

@ast

Type 1 Diabetes Prevention in ...... CD8⁺T Effector Memory Subset.

@en

prefLabel

Type 1 Diabetes Prevention in ...... CD8⁺T Effector Memory Subset.

@ast

Type 1 Diabetes Prevention in ...... CD8⁺T Effector Memory Subset.

@en

P1476

Type 1 Diabetes Prevention in ...... CD8⁺T Effector Memory Subset.

@en

P2093

Aina Teniente

http://www.w3.org/2001/XMLSchema#string

Irma Pujol-Autonell

http://www.w3.org/2001/XMLSchema#string

Jorge Carrascal

http://www.w3.org/2001/XMLSchema#string

María Carmen Ruiz de Villa

http://www.w3.org/2001/XMLSchema#string

María Teresa Julián

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo.

The NOD mouse model of type 1 diabetes: as good as it gets?

Sitagliptin (MK0431) inhibition of dipeptidyl peptidase IV decreases nonobese diabetic mouse CD4+ T-cell migration through incretin-dependent and -independent pathways.

A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice.

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study.

Efferocytosis promotes suppressive effects on dendritic cells through prostaglandin E2 production in the context of autoimmunity.

Enhancing pancreatic Beta-cell regeneration in vivo with pioglitazone and alogliptin.

The multifunctional or moonlighting protein CD26/DPPIV.

P304

e0142186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0142186

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marta Vives-Pi

Manuel Puig-Domingo

Roger Colobran

Antonio Miñarro Alonso

Marco A Fernandez

Silvia Rodríguez-Fernández

Nuria Alonso

P577

2015-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283684400

http://www.w3.org/2001/XMLSchema#string

P698

26555789

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

4640511

http://www.w3.org/2001/XMLSchema#string

Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset.

about

P2860

P2860

Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932